GlassScriptPhysician profile
Twilla M Walker
NPI 1770756512
$7,019.69
in general payments reported to CMS, 2019-2025
36 companies · $1,295 in 2025
The $1,295 reported for 2025 was more than what 90% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,753 · 2022: $1,283 · 2023: $1,138 · 2024: $1,550 · 2025: $1,295.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,983.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,983.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $720.68 | 2021-2025 | Jardiance |
| Janssen Pharmaceuticals, INC | $547.21 | 2021-2024 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $503.63 | 2022-2025 | Camzyos, Eliquis |
| Novartis Pharmaceuticals Corporation | $487.32 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $463.97 | 2021-2025 | Farxiga, Wainua, Lokelma |
| Amgen INC. | $462.43 | 2021-2025 | Repatha, Repatha |
| Merck Sharp & Dohme LLC | $392.70 | 2021-2025 | Verquvo |
| Pfizer INC. | $364.58 | 2021-2025 | |
| Actelion Pharmaceuticals US, INC. | $355.90 | 2021-2024 | Opsumit, Uptravi |
| Bayer Healthcare Pharmaceuticals INC. | $265.76 | 2021-2025 | |
| Scpharmaceuticals INC. | $222.27 | 2023-2025 | |
| Abiomed | $216.22 | 2024-2025 | Impella |
| Abbott Laboratories | $212.54 | 2021-2025 | Cardiomems, Amplatzer |
| Cvrx, INC. | $210.48 | 2024-2025 | Barostim Neo System |
| Sanofi-Aventis U.S. LLC | $194.74 | 2021-2024 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $192.47 | 2023-2025 | Symplicity G3, Arctic Front Advance |
| Novo Nordisk INC | $165.34 | 2021-2025 | Wegovy, Ozempic, Rybelsus |
| Lexicon Pharmaceuticals, INC. | $130.51 | 2023-2025 | Inpefa |
| Kiniksa Pharmaceuticals International, Plc | $123.41 | 2024 | Arcalyst |
| Amarin Pharma, INC. | $118.51 | 2021-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $96.12 | 2021-2025 | Lifevest |
| Kiniksa Pharmaceuticals, LTD. | $78.77 | 2022-2023 | Arcalyst |
| Inspire Medical Systems, INC. | $68.76 | 2025 | Inspire |
| Esperion Therapeutics, INC. | $66.40 | 2021 | |
| Boston Scientific Corporation | $57.84 | 2024-2025 | Watchman Flx, Bodyguardian |
| Regeneron Healthcare Solutions, INC. | $44.17 | 2023-2024 | Evkeeza |
| Baxter Healthcare | $42.95 | 2023 | Hillrom - Carnation Ambulatory Monitor |
| Lundbeck LLC | $41.04 | 2021 | |
| Irhythm Technologies, INC. | $35.62 | 2022-2023 | Zio Xt Patch |
| Arbor Pharmaceuticals, INC. | $33.35 | 2021 | |
| Abbvie INC. | $20.84 | 2023 | |
| Atricure, INC. | $19.42 | 2022 | |
| Impulse Dynamics (USA) INC. | $17.54 | 2025 | Optimizer |
| Kestra Medical Technology Services, INC. | $16.10 | 2024 | Assure Wcd |
| Philips North America LLC | $15.32 | 2022 | |
| Glaxosmithkline, LLC. | $14.78 | 2025 | Shingrix, Arexvy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Twilla Walker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.